By David Robinson
April 3, 2024 | BioVentures LLC at UAMS recently announced the selection of three UAMS research teams as the inaugural recipients of its new AR Health Ventures Accelerator (ARHVA) program.
The accelerator program, which aims to help jump-start the translation of promising scientific discoveries into therapies, is providing the selected projects with substantial benefits, including financial grants up to $50,000 for projects to be completed in six months, project management, budget allocation and progress tracking.
“I am excited to see the AR Health Ventures Accelerator program become a reality,” said John Imig, Ph.D., BioVentures vice president of Technology Acceleration and leader of the ARHVA program. “This program will address significant gaps in advancing investigator ideas and research towards therapeutic products, ultimately enhancing patient care.”
Click HERE for more.